Study shows no benefit from active ingredient in common cold medicine

by Eric Peters

(Medical Xpress)—Glyceryl guaiacolate ether (GGE), the active ingredient in many popular over-the-counter cold remedies, is unlikely to make it easier to cough up phlegm when delivered in the recommended dose, according to a Virginia Commonwealth University study.

A total of 295 subjects completed the eight-day, multi-center clinical trial in which sputum samples were collected and measured for their volume and properties. At the end of the study, authors concluded that "extended–release GGE administered at the recommended dose is no more effective than a placebo in changing sputum properties."

The study was published in the May 2014 issue of the journal Respiratory Care. Bruce Rubin, M.D., the Jessie Ball DuPont Distinguished Professor and chair of the Department of Pediatrics at the VCU Medical Center and physician-in-chief of the Children's Hospital of Richmond at VCU, is a lead author.

"This study is consistent with smaller studies that have shown that guaifenesin has no measurable effect on sputum properties or clearance when taken by otherwise healthy adults who get a common cold," Rubin said. "Although we did not study people with chronic bronchitis or other mucus problems, it is very unlikely that any benefit perceived by people who take medications containing guaifenesin is due to clearing out airway mucus."

More information: Agathe Hoffer-Schaefer, Henry J Rozycki, Melissa A Yopp, and Bruce K Rubin, "Guaifenesin Has No Effect on Sputum Volume or Sputum Properties in Adolescents and Adults With Acute Respiratory Tract Infections," Respir Care, May 2014 59:5 631-636; published ahead of print September 3, 2013, DOI: 10.4187/respcare.02640

add to favorites email to friend print save as pdf

Related Stories

Misuse of Vicks VapoRub may harm infants and toddlers

Jan 13, 2009

Vicks® VapoRub®, the popular salve used to relieve symptoms of cough and congestion, may be harmful for infants and toddlers. New research appearing in the January issue of Chest, the peer-reviewed journal of the Americ ...

Doubling up on cold, flu remedies may harm liver

Jan 30, 2013

(HealthDay)—Taking too much acetaminophen, an active ingredient in many commonly used drugs for fever and pain relief, including Tylenol, can cause liver damage, experts at the U.S. Food and Drug Administration ...

Recommended for you

Ebola vaccine promising in first human trials

4 hours ago

Researchers say they are one step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

At one month, US Ebola monitors finding no cases

7 hours ago

The U.S. program that requires weeks of monitoring for travelers from African countries with Ebola reaches the one-month mark Thursday. And so far, no cases of the disease have turned up.

EU calls for 5,000 doctors to fight Ebola

8 hours ago

The European Commission called for 5,000 doctors to be sent from EU states to combat west Africa's Ebola epidemic, a European source with knowledge of the matter said on Wednesday.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Nik_2213
not rated yet May 09, 2014
This is a badly written article.
"Study shows no benefit from active ingredient in common cold medicine"
vs
"...when taken by otherwise healthy adults who get a common cold."
&
"...we did not study people with chronic bronchitis or other mucus problems."

Silly !!
IIRC, guaifenesin helps shift snot from deep in your lungs, not from your sinuses. Antihistamines *may* help there, by mitigating the eye-watering, nose-streaming itching.

( Your mileage may vary. Follow medical advice etc etc etc... )

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.